Skip to Global Health Initiative Full Site Menu Skip to main content
October 23, 2020

Safeguarding the Bioeconomy

Biosecurity Needs a Security Patch...Badly

Event Series: Global Health Security Seminars

This is a picture of a bench in a laboratory with vials.

Biological threats have historically focused on addressing emerging infectious diseases or the possibility of engineering a virus that could start the zombie apocalypse. Today, as biology continues to converge with the cyber realm, new security challenges will arise. In the area of health care, there is a general failure to recognize biological data as a potential economic driver and therefore a national security concern. This presentation by Special Agent Edward You will highlight the need to radically redefine what we consider a biological threat. 

A supervisory special agent in the FBI’s Weapons of Mass Destruction Directorate, Mr. You is responsible for creating programs and activities to coordinate and improve FBI and interagency activities to identify, assess, and respond to biological threats or incidents. He has also been directly involved in policy-making efforts with a focus on biosecurity. His overall goal is to safeguard the scientific community, the life science research enterprise, and the U.S. bioeconomy.

The Georgetown University Global Health Initiative (GHI) and Georgetown Center for Global Health Science and Security (GHSS) are co-sponsoring this event as part of the Global Health Security Seminar Series.

Instructions to join the event will be sent via email prior to the event to anyone who has filled out the RSVP form by 5:00 p.m. EDT on October 22. The event will be recorded and a captioned video will be posted to this page after the event date. Please RSVP to receive an email notification once it is posted.


Edward You is a supervisory special agent in the FBI’s Weapons of Mass Destruction Directorate, currently detailed as a liaison officer at the Department of Health and Human Services Office of National Security. Prior to joining the FBI, Mr. You had worked for three years in autoimmune disease research at the Cedars-Sinai Medical Center and six years in human gene therapy and retrovirology at the University of Southern California Keck School of Medicine.